However, insulin initiation and intensification present clinical challenges that may compromise adherence, often leading to simplified fixed-dose regimens
Other formulations may not qualify under the current CMS list
On the other hand, Wegovy is specifically approved for weight loss and contains a higher dose of semaglutide, making it more effective for shedding pounds
In humans, changes in intestinal permeability have been linked in the pathogenesis of debilitating inflammatory bowel diseases (IBDs) such as Crohns disease (CD) [1] and in autoimmune diseases such as Celiac disease [2]
A provider practicing within the United States can also review whether a dose adjustment is appropriate, since some people find that a slower titration schedule reduces digestive side effects while still allowing them to reach their treatment goal
Zugasti I, Espinosa-Aroca L, Fidyt K et al (2025) CAR-T cell therapy for cancer: current challenges and future directions